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Cerebral ischemia is a complex pathology involving a cascade of cellular mechanisms,
which deregulate proteostasis and lead to neuronal death. Proteostasis refers to the
equilibrium between protein synthesis, folding, transport, and protein degradation.
Within the brain proteostasis plays key roles in learning and memory by controlling
protein synthesis and degradation. Two important pathways are implicated in the
regulation of proteostasis: the unfolded protein response (UPR) and macroautophagy
(called hereafter autophagy). Both are necessary for cell survival, however, their over-
activation in duration or intensity can lead to cell death. Moreover, UPR and autophagy
can activate and potentiate each other to worsen the issue of cerebral ischemia.
A better understanding of autophagy and ER stress will allow the development of
therapeutic strategies for stroke, both at the acute phase and during recovery. This
review summarizes the latest therapeutic advances implicating ER stress or autophagy
in cerebral ischemia. We argue that the processes governing proteostasis should be
considered together in stroke, rather than focusing either on ER stress or autophagy
in isolation.
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Abbreviations: 3-MA, 3-methyladenine; AMP, adenosine monophosphate; AMPAR, α-amino-3-hydroxy-5-methyl-4-
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activating transcription factor 6; Atg, autophagy-regulated; Atg16L1, Atg16-like 1; ATP, adenosine triphosphate; Baf,
bafilomycin; BBB, blood-brain barrier; BCAo, Bilateral cerebral artery occlusion; Bcl-2, B cell lymphoma 2; BiP, binding
immunoglobulin protein; BMVECs, brain microvascular endothelial cells; CA, cornu ammonis; CHOP, CCAT/enhancer
homologous protein; CICR, calcium-induced calcium release; CMA, chaperone-mediated autophagy; CREB, cAMP response
element binding protein; CSF, cerebrospinal fluid; DAPK1, death-associated protein kinase 1; eIF2α, eukaryotic translation
initiation factor 2α; ER, endoplasmic reticulum; ERAD, ER-associated protein degradation; FIP200, focal adhesion kinase
family interacting protein of 200 kDa; FOXO1, forkhead box O1; GABARAP, -aminobutyric acid receptor-associated
protein; GADD34, growth arrest and DNA damage inducible 34; GATE-16, Golgi-associated ATPase enhancer of 16 kDa;
GFAP, glial fibrillary acidic protein; GFP, green fluorescence protein; Grp78, Glucose regulated protein 78; HI, hypoxia-
ischemia; HIF-1α, hypoxia-inducible factor-1α; hsc70, heat-shock cognate protein of 70 kDa; IP3R, inositol trisphosphate
receptor; IPC, ischemic preconditioning; IRE1, inositol-requiring enzyme 1; JNK1, Jun N-terminal kinase 1; LAMP2A,
lysosomal-associated membrane protein 2A; LC3, light chain 3; miR-9a-5p, micro-RNA-9a-5p; mTOR, mammalian target
of rapamycin; mTORC1, mammalian target of rapamycin complex 1; NF-κB, Nuclear factor-κB; NMDA, N-methyl-D-
aspartate; OGD, oxygen and glucose deprivation; P70S6K, P70 ribosomal protein S6 kinase; PE, phosphatidylethanolamine;
PERK, protein kinase R-like endoplasmic reticulum kinase; PI3K, phosphatidylinositol 3-kinase; PI3P, phosphatidylinositol
3-phosphate; pMCAO, permanent model of middle cerebral artery occlusion; Rheb, Ras homolog enriched in brain; RIP1K,
receptor-interacting protein 1 kinase; SERCA, sarcoendoplasmic reticular calcium-ATPase; SGK, serum and glucocorticoid
kinase; siRNA, small interfering RNA; SNAP29, synaptosomal-associated protein 29; SNARE, soluble N-ethylmaleimide-
sensitive-factor attachment protein receptor; SQSTM1, sequestosome 1; STX17, syntaxin 17; tMCAo, transient MCAo; tPA,
tissue-type plasminogen activator; TSC1/2, tuberous sclerosis complex 1 and 2; TSC2, tuberous sclerosis complex 2; ULK1,
Unc-51-like kinase; UPR, unfolded protein response; VAMP8, vesicle-associated membrane protein 8; VPS15, vacuolar
protein sorting 15; VPS34, vacuolar protein sorting 34; XBP1, X-box bonding protein 1.
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INTRODUCTION
Cerebral ischemia is a major cause of adult mortality and
disability in developed countries. It is characterized by a
reduction of cerebral blood flow, leading to a dramatic drop
of energetic supply, altered cellular homeostasis and finally
cell death (Doyle et al., 2008; Yepes et al., 2009). Several
pathways leading to neuronal death are activated during ischemic
events. Historically, glutamate receptor-mediated excitotoxicity,
apoptosis and inflammation have been shown to be important
parts of ischemia-mediated neuronal death (Dirnagl et al., 1999).
More recently, ER stress via the UPR (Roussel et al., 2013)
and autophagy (Liu et al., 2010) pathways, either at the acute
phase or during recovery, has received much attention in the
stroke research field.
To date, only two therapeutic approaches are available
to promote reperfusion during ischemic stroke: the recent
mechanical clot removal (endovascular thrombectomy),
and thrombolysis by tPA (Thiebaut et al., 2018). Of note,
tPA administration is often combined with endovascular
thrombectomy, especially in patients with large vessel occlusion
(Berkhemer et al., 2015). However, both treatments have their
own limits: tPA has a narrow therapeutic window (4.5 h after
stroke onset) (Hacke et al., 2008), presents a risk of hemorrhagic
transformation and has a low recanalisation rate (National
Institute of Neurological Disorders and Stroke rt-Pa Stroke
Study Group, 1995; Thiebaut et al., 2018); while endovascular
thrombectomy is restricted to large vessel occlusions (Berkhemer
et al., 2015). Several strategies of neuroprotection have been
tested in stroke, but no clinical trials have demonstrated any
beneficial effect in patients (Young et al., 2007). To overcome this
challenge, better stroke models and trial designs are required,
and integration of multiple complex signaling pathways will
be necessary to provide a complete understanding of stroke
(Karsy et al., 2017).
Among such pathways, those maintaining proteostasis appear
especially relevant as they encompass many responses, from
changes in protein synthesis and folding to secretion and
degradation. Moreover, altered proteostasis is implicated in both
the acute and recovery phases of stroke (Wang and Yang, 2018).
The UPR, which is the proteostasis control system affecting the
ER, maintains the balance between protein synthesis, folding
and degradation within the organelle (Roussel et al., 2013).
On the other hand, protein or organelle degradation during
stroke is mainly driven by autophagy (with ubiquitination and
SUMOylation), and more particularly, macroautophagy (called
hereafter autophagy) (Liu et al., 2010).
AUTOPHAGY AND CEREBRAL
ISCHEMIA
Autophagy is a protein degradation system highly conserved
in all eukaryotes. Its name comes from Greek roots: “auto”
which means “self ” and “phagy” which means “eating.” This
self-protecting catabolic process is required for restoring cellular
homeostasis under nutrient starvation or metabolic stress by
degrading or recycling long-lived or misfolded proteins and
damaged organelles (Klionsky et al., 2016). Depending on the
mode of cargo delivery, three types of autophagy have been
described: microautophagy, CMA and macroautophagy.
Microautophagy is a non-selective lysosomal degradative
process referring to as the direct engulfment of cytoplasmic
materials by the lysosome. In microautophagy, the lysosomal
membrane is randomly invaginated to trap portions of the
cytosol (Figure 1A). Microautophagy is known to play several
roles, such as the regulation of the ratio of lipid to protein
at the lysosomal surface, the maintenance of organelle size,
the membrane composition and lipid metabolism. It can occur
simultaneously with macroautophagy or simply be a constitutive
method to degrade long-lived proteins and membrane proteins
(Iwata et al., 2005; Krick et al., 2009).
Chaperone-mediated autophagy is a selective lysosomal
degradative process requiring the presence within the substrate
protein of a specific amino acid motif recognized by the
chaperone hsc70. All cargo recognized by hsc70 are delivered
to lysosomes where they bind to the LAMP2A (Bandyopadhyay
et al., 2008; Figure 1B). Then, they are translocated one-by-
one into lysosomes assisted by a chaperone located in the
lysosomal lumen. CMA contributes to protein quality control
through selective removal of altered or damaged proteins
(Zhang and Cuervo, 2008).
In contrast to microautophagy and CMA, macroautophagy
involves sequestration of the cargo away from the lysosome.
Macroautophagy requires the synthesis of an autophagosome,
a double-layered membrane structure, to transport cellular
cargo targeted for degradation. Autophagosomes then fuse
with lysosomes to form autophagolysosomes resulting in
the degradation of their contents (Figure 1C). Because
macroautophagy is the most abundant and characterized
form of autophagy, our review will primarily focus on its
mechanisms and effects in cerebral ischemia.
Autophagy occurs at a basal level in all mammalian cells
and is regulated by conditions such as starvation, oxidative
stress or hypoxia, and can also be triggered by obesity, diabetes,
inflammation and cancer. The induction of autophagy appears as
a promising therapeutic strategy for neurodegenerative diseases
with protein misfolding and aggregation (Alzheimer’s diseases,
Parkinson’s disease, Tauopathies, Huntington’s disease, and
various spinocerebellar ataxias) (Rubinsztein et al., 2012).
Autophagy Mechanisms in
Physiopathological Conditions
Autophagy Processes and Signaling Pathway
The most common experimental approaches to induce
autophagy are either nutrient starvation and or the use of
rapamycin to inhibit the mTOR. Autophagy activates the
ULK1 complex (ULK1, also known as Atg1 for intervention
of autophagy-regulated 1), Atg13, and FIP200 (Noda and
Ohsumi, 1998). The ULK1 complex also regulates the activation
of a class III PI3K complex formed by Beclin-1, VPS34, and
VPS15. When phosphorylated by ULK1, Beclin-1 promotes the
generation of PI3P by VPS34, which upgrades autophagosomal
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FIGURE 1 | Schematic model of autophagy. (A) Macroautophagy is the result of the fusion of an autophagosome, a double membrane vacuole transporting cellular
cargo that has been targeted for degradation, with a lysosome. (B) Microautophagy is a non-selective lysosomal degradative process that involves direct engulfment
of cytoplasmic materials by the invagination of the lysosome. (C) Chaperone-mediated autophagy involves the direct translocation, through LAMP2A, of specific
proteins containing a motif recognized by a chaperone named hsc70 (heat-shock cognate protein of 70 kDa).
membrane nucleation (Russell et al., 2013; Figure 2A). On the
other hand, Beclin-1 can bind to the anti-apoptotic protein
Bcl-2 leading to the inhibition of autophagy (Pattingre et al.,
2005). In response to starvation, JNK1 phosphorylates Bcl-2
allowing its release from Beclin-1 and the induction of autophagy
(Pattingre et al., 2009; Figure 2B).
In addition to these two complexes, other Atg proteins are
hierarchically required for the biogenesis of autophagosomes.
Atg5 and Atg12, co-operate with Atg7, to promote the
formation of an Atg5-Atg12- Atg16L1 complex, and thus
facilitate the cargo recruitment and autophagosomes membrane
elongation. The microtubule-associated protein light chain 3
(LC3, also named Atg8) is cleaved by Atg4 to yield LC3-
I, then, LC3-I is conjugated to PE by Atg7 and Atg3 to
become LC3-II (Mizushima et al., 2011). p62, also called
SQSTM1, binds to ubiquitinated proteins, targeting them for
degradation into autolysosomes through its binding to LC3-
II in the autophagosome (Myeku and Figueiredo-Pereira,
2011). LC3-II is essential for phagophore formation, with the
participation of GABARAP/GATE-16 subfamily members in
later stages of autophagosome formation, in particular for
phagophore elongation, closure and fusion (Weidberg et al.,
2010). Autophagosome can acquire membranes from multiple
sources including the ER, the Golgi apparatus, the plasma
membrane and the mitochondrial outer membrane. This process
requires the involvement of the only transmembrane Atg protein,
Atg9, which is present in single-membrane vesicles providing
membranes for early autophagosome formation (Yamamoto
et al., 2012). The fusion between the autophagosome and the
lysosome requires the recruitment from the ER and mitochondria
of the SNARE protein STX17. STX17 interacts with SNAP29
and VAMP8 to form a trans-SNARE complex and mediates
autophagosome-lysosomes fusion (Itakura et al., 2012).
Autophagy Activation in Brain Ischemia
Nitatori et al. (1995) were the first to demonstrate, by
electron microscopy, an increase in cathepsin B-immunopositive
lysosomes, in the CA1 pyramidal neurons 3 days after an ischemic
insult. Since then, the evidence for activation of autophagy has
continued to accumulate. For example, beclin 1 is activated
and associated to a LC3-II increase following neonatal hypoxia-
ischemia (HI) (Carloni et al., 2008) and focal cerebral ischemia
(Rami et al., 2008). In neonatal cerebral HI, in addition to
the increase in autophagosomal formation (characterized by
an increase of LC3-II), there is also an increase of lysosomal
activity in damaged cortical and CA3 neurons, suggesting an
increase in the autophagic flux (Ginet et al., 2009). These results
are confirmed in a pMCAO. Moreover, immunofluorescence
shows strong co-localisation of autophagosomal puncta (LC3-II)
and lysosomes (cathepsin D and LAMP1) (Puyal et al., 2009).
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FIGURE 2 | Continued
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FIGURE 2 | Autophagy signaling pathway. Autophagy is induced by an energetic stress, leading to AMPK activation; or by growth factors starvation, leading to the
inhibition of the class I phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway. Two complexes can be involved in autophagy
induction: ULK1 complex composed of autophagy-regulated 101 (Agt1), Atg101, FIP200, and ULK1 and class III PI3K complex form by Beclin-1, vacuolar protein
sorting 34 (VPS34) and vacuolar protein sorting 15 (VPS15). (A) Schematic illustration of autophagy initiation and autophagosome formation. Different Atg proteins
including Atg5-Atg12-Atg16L and the microtubule-associated protein LC3-II are involved in double membrane elongation and in autophagosome-lysosome fusion.
P62 binds to ubiquitinated proteins targeting them for degradation in the autolysosomes. Rapamycin can activate autophagy by inhibiting mTOR Complex 1. Both
3-MA (3-methyladenine), chloroquine and Bafilomycin are autophagy inhibitors by, respectively, inhibiting Class III PI3K complex and autophagosome/lysosome
fusion. (B) Schematic illustration of cross talk and interaction among autophagy, apoptosis and necroptosis during brain ischemia. The dissociation of Beclin1 and
Bcl-2 is also responsible of autophagy increase. The receptor interacting protein (RIP) Kinase 1 activation by death receptors, such as Fas, TLR4 and TNFR1, is
responsible of Jun N-terminal kinase 1 (JNK1) pathway activation, ROS (reactive oxygen species) release and necroptosis. RIP1 interacts with FADD (Fas-Associated
protein with Death Domain) and TRADD (Tumor necrosis factor receptor type 1-associated DEATH domain protein) to induce extrinsic apoptosis. RIP1 is also
involved in intrinsic (mitochondrial) apoptosis through cytochrome C release which activates caspase-9 and capase-3.
Furthermore, a study with 37 acute ischemic stroke patients
revealed that CSF and serum levels of both Beclin-1 and LC3
are increased compared to control patients (Li et al., 2015),
suggesting that autophagic cells die and release these markers in
the circulation. Levels of Beclin1 and LC3 in CSF are positively
correlated with infarct volumes and the severity of neurological
deficits (NIHSS and Modified Rankin Scale) (Li et al., 2015).
In addition, the expression of autophagic and apoptotic genes
is increased in blood samples of ischemic stroke patients (Guo
et al., 2017). However, Liu et al. (2010) reported that autophagy
pathway is up-regulated after cerebral ischemia/reperfusion, but
fails to operate correctly. They propose the idea that at least a part
of the accumulation of protein aggregate-associated organelles
seen following ischemia is due to the failure of autophagosomes
to fuse with lysosomes (Liu et al., 2010).
After brain ischemia, autophagy-related signaling pathways
are dramatically activated. In neonatal HI, Akt and CREB are
activated in neurons and both phospho-Akt and phospho-
CREB colocalized with Beclin-1. In this model, it has been
shown that activation of autophagy activated by rapamycin was
neuroprotective, and this was associated with the activation of
Akt/CREB signaling (Carloni et al., 2010). During ischemia, a
decrease in ATP concentration increases the AMP/ATP ratio
and activates AMPK. Active AMPK leads to phosphorylation of
TSC1/2 (tuberous sclerosis proteins 1 and 2) and inhibition of
mTORC1 activity through Rheb. Several groups have reported
the involvement of AMPK signaling pathway in the mediation
of autophagy-related neuroprotection in brain ischemia (Wang
et al., 2012; Gabryel et al., 2014; Jiang et al., 2014; Dai et al., 2017).
Conversely, a study has shown that inhibition of AMPK activity
inhibits autophagy and alleviates focal cerebral ischemia injury in
mice by restoring mTORC1 activity (Fu et al., 2016). Autophagy
may also be increased by the HIF-1α, a key transcription factor
activated by the low oxygen conditions observed during cerebral
ischemia (Xin et al., 2011; Yang et al., 2014; Zhang et al., 2018).
Role of Autophagy in Cerebral Ischemia
While brain ischemia is known to induce autophagy, its
protective or deleterious role remains unclear. Indeed, in vitro
and in vivo studies report contradictory effects of autophagy
induction during ischemia.
Neuronal Autophagy in the Ischemia Brain
Neuronal autophagy occurs early during cerebral ischemia, with
autophagosomes and autolysosomes detectable just 1 h after
pMCAo, and increasing up to 12 h thereafter (Wen et al.,
2008). In line with this, Tian et al. (2010) showed, using GFP-
LC3 transgenic mice, increased levels of autophagosomes in the
ipsilateral hemisphere at 1, 3, and 6 days following tMCAo, with a
peak at 1 day. The cells containing GFP-LC3-punctae were mostly
neurons (Tian et al., 2010). Indeed, during cerebral ischemia,
autophagy is predominantly a neuronal phenomenon (Carloni
et al., 2008; Rami et al., 2008; Ginet et al., 2009; Puyal et al., 2009).
Autophagy and Neuronal Death in Brain
Ischemia
After cerebral ischemia, the number of GFP-
LC3-punctae/TUNEL (terminal deoxynucleotidyl
transferase-mediated dUTP-digoxigenin nick end labeling)
double-positive cells increases in both the core and the peri-
ischemic area (Tian et al., 2010). In addition, dying neurons
displaying intense vacuolisation and numerous autophagosomes
are detected 6 h after HI in neonatal rats, with a peak at
24 h. These dying neurons display some features of apoptosis
such as chromatin condensation, cytoplasmic shrinkage, and
relatively well-preserved organelles, suggesting that autophagy
could precede apoptosis (Ginet et al., 2009). Uchiyama (2001)
have shown that inhibiting autophagy protects neuron-like
differentiated PC12 cells from apoptosis following serum
deprivation, suggesting that autophagy is involved in neuronal
cell death in vitro. This association between neuronal death and
autophagy has led to the term “autophagic death” (Figure 2B).
Beclin 1 has been reported to be involved in autophagic
death. RNAi against Beclin-1 reduces neuronal autophagy and
apoptosis in tMCAo model (Zheng et al., 2009). In addition,
Beclin 1 knockdown inhibits autophagosomal formation and
alleviates apoptotic neurodegeneration in the ipsilateral thalamus
following focal ischemia (Xing et al., 2012).
Apoptosis is not the only mechanism involved in
ischemia-induced cell death. In 2005, a study shown that
an intracerebroventricular injection of necrostatin-1, an
inhibitor of necroptosis (programmed necrosis), decreases the
infarct volume in a mouse MCAo model (Degterev et al., 2005).
A recent work demonstrates in a pMCAo model, that the RIP1K-
regulated necroptosis contribute to ischemia-mediated neuronal
and astrocytic cell death through the activation of autophagic
pathways (Ni et al., 2018). Furthermore, necrostatin-1 decreases
LC3-II level and autophagy (Ni et al., 2018). On the other hand,
pre-treatment with 3-MA, an inhibitor of autophagy and PI3K,
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prevents neuronal necroptosis at 7 days of reperfusion in a severe
model of global cerebral ischemia (Wang et al., 2011).
Despite controversial findings suggesting that ischemia
induces autophagy only in the hippocampal CA1 region (Gao
et al., 2015), it has been suggested that hippocampal CA1
and CA3 regions present a differential response to ischemia-
induced autophagy, with CA1 neurons mostly undergoing
apoptosis without autophagy, while CA3 neurons mostly
undergo autophagic death (Ginet et al., 2009; Papadakis et al.,
2013). The reasons for these subpopulation differences remain
to be established.
Deleterious Autophagy in Brain Ischemia
In both primary cultures of neurons and SH-SY5Y cells subjected
to OGD, autophagic cell death occurs and can be reversed by
3-MA, a PI3Ks inhibitor (Shi et al., 2012). Bao et al. (2017)
suggest that this effect is dependent of autophagy-induced
AMPAR subunits GluR1, GluR2, and GluR3 upregulation during
OGD, leading to an increase of cytoplasmic Ca2+ levels. In rats
subjected to transient focal cerebral ischemia, intraventricular
injection of 3-MA dramatically reduces the lesion volume
(by 46%) whereas an inhibitor of apoptosis does not provide
protection (Puyal et al., 2009). Several inhibitors of autophagy
(3-MA, bafilomycin, and the cathepsin B inhibitor Z-FA-
fmk) significantly reduce the increase of autophagosome and
autolysosome, the downregulation of Bcl2, infarct volume, brain
oedema and motor deficits in a rat model of pMCAO (Wen et al.,
2008). Thus, it seems that decreasing autophagy both in vitro and
in vivo during cerebral ischemia is beneficial (Cui et al., 2013;
Jiang et al., 2017; Ryan et al., 2018).
Knocking down Beclin1 and Atg7 with siRNA reduce
autophagy and excitotoxic cell death induced by both kainate and
hypoxia in primary neurons (Ginet et al., 2014). Atg7 deficient
mice show nearly complete protection from HI-induced caspase-
3 activation and hippocampal pyramidal neuronal death (Koike
et al., 2008). Furthermore selective neuronal deletion of Atg7
reduces autophagy and infarct volume by 42% in neonatal mice
subjected to HI (Xie et al., 2016). Overexpression of microRNA-
9a-5p (miR-9a-5p) decreases Atg5 protein level, leading to a
decrease of infarct volume and neurological deficit in a rat model
of MCAo (Wang et al., 2018).
Protective Autophagy in Brain Ischemia
In Wang et al. (2012) have shown that 3-MA pre-treatment is
deleterious in a rat model of MCAo. The inhibition of autophagy
by 3-MA or wortmannin, both PI3Ks inhibitor, accelerates the
progression toward necrotic cell death in neonatal HI model.
Conversely, rapamycin, increases Beclin 1 expression and reduces
necrotic cell death and brain damage (Carloni et al., 2008). Both
ischemic preconditioning (IPC) and permanent focal ischemia
induce autophagy activation by up-regulating LC3-II and Beclin-
1. IPC treatment significantly reduces infarct volume, brain
oedema and motor deficits, whereas 3-MA and bafilomycin
suppress IPC-induced neuroprotection (Sheng et al., 2010). The
neuroprotective action of rapamycin has been confirmed in
several models of MCAo (Chauhan et al., 2011; Buckley et al.,
2014). Finally, neuronal autophagy upon brain ischemia seems
to be a part of pro-survival signaling pathway, that involves
PI3K/Akt/TSC2 /mTOR/P70S6K signaling pathway (Wang et al.,
2012; Papadakis et al., 2013) and Akt/CREB pathway (Carloni
et al., 2010). IPC-induced autophagy is also neuroprotective and
this effect has been suggested to be dependent of the amelioration
of ER stress (Sheng et al., 2012). Inhibition of autophagy with
Atg7 knock down increase ischemia-induced neuronal apoptosis
in OGD and MCAo model. Mitochondrial clearance is reversed
by 3-MA and Atg7 silencing, suggesting that mitophagy underlies
the neuroprotection by autophagy (Zhang et al., 2013). Moreover,
Atg7 silencing reverses the neuroprotection induced by an ER
stress activator (Zhang et al., 2014). In fact both tunicamycin and
thapsigargin protect against ischemic brain injury by activating
mitochondrial autophagy during reperfusion. Interestingly, this
effect is reversed by the inhibition of autophagy (Zhang et al.,
2014). Knocking out arrestin-β1, which is upregulated after
cerebral ischemia, protects neurons from OGD by impairing
the interaction between Beclin-1 and PIK3 catalytic subunit
type 3, thus decreasing autophagy (Wang et al., 2014). Beclin-
1 seems central, as caveolin1, an integral membrane protein,
is able to activate autophagy through its binding to Beclin-
1/VPS34 complex: in Caveolin1 knock out mice, autophagy is
impaired, leading to greater tMCAo-induced cerebral infarct
(Nah et al., 2017).
Endothelial Autophagy in Brain Ischemia
In Engelhardt et al. (2015) have published a comparative
study to characterize BBB-associated cells responses to HI.
BMVECs exhibit greater responsiveness and sensitivity to OGD
than astrocytes and pericytes. This is associated with the
stabilization of HIF-1α, early disruption of cellular cytoskeleton
and metabolism impairment, but unlike perivascular cells,
BMVECs appear unable to induce autophagy. BMVECs are
specialized endothelial cells, connected by tight junction and
display intimate contact with supporting pericytes, astrocytes,
microglia, and neurons in order to maintain the structural
and functional integrity of the BBB. Brain ischemia and
thrombolysis therapy with tPA induce BBB disruption, brain
oedema and neuronal injury (Thiebaut et al., 2018). Several
groups support the idea that autophagy induces endothelial
cell injury and BBB disruption. Indeed focal ischemia, in
NF-κB p50 knockout mice, induces autophagy like-injury in
BMVECs together with a disruption of BBB integrity (Li
et al., 2013). It appears that autophagy is beneficial for
BMVECs and BBB integrity. In Li et al. (2014) shown that
enhancing autophagy by rapamycin and lithium reverses OGD-
induced collapsing of tight junction and decreases tMCAo-
induced BBB leakage and brain oedema; while 3-MA intensifies
BMVECs apoptosis. Supporting these results, the knockdown
of Beclin-1 attenuates autophagy processes and reduces the
viability of endothelial cells subjected to OGD, while treatment
with rapamycin increases cell viability (Urbanek et al., 2014).
Similarly, chloroquine-induced autophagy inhibition enhances
BBB permeability during pMCAo in diabetic rats. By opposition
to the results of Engelhart and collaborators, this group
observed autophagy activation in BMVECs after ischemia
(Fang et al., 2015).
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Astrocytic Autophagy in Brain Ischemia
During brain ischemia, glial cells, especially astrocytes,
play a crucial role. They are involved in water transport,
ion homeostasis, glutamate uptake, cerebral blood flow
regulation, cerebral inflammation, maintenance of the
BBB integrity, modulation of neuroplasticity and the
secretion of neurotrophic and neuroprotective factors
(Nedergaard et al., 2003).
In Tian et al. (2010) have shown, in a mouse model of
MCAo, that GFP-LC3-punctae positive cells were mostly neurons
rather than astrocytes or microglial cells in the peri-ischemic
area, suggesting that glial cells may be more resistant to
brain ischemia-induced autophagy than neurons. Nonetheless,
a few groups report that ischemia induces an increase of
astrocytic autophagy (Qin et al., 2010; Zhang et al., 2010;
Engelhardt et al., 2015). Autophagosomes start to appear in
the cytoplasm of astrocytes within the ischemic cortex 1 h
after pMCAo and in the cytoplasm of primary astrocytes
1 h after OGD, with a peak at 3 h (Qin et al., 2010). The
number of lysosomes significantly increases 6 h after pMCAo
and OGD. In addition, they observe an increase of LC3-
II, Beclin-1, LAMP2 and lysosomal cathepsin B expression.
3-MA and bafilomycin decrease ischemia-induced autophagy,
apoptosis and necrosis, suggesting that autophagic/lysosomal
activation may contribute to ischemic injury of astrocytes
(Qin et al., 2010). This is partially confirmed by the fact
that RIP1K knockdown decreases autophagy, increases GFAP
levels, and attenuates astrocytic necrotic cell death in the
ischemic cortex (Ni et al., 2018). RIP1K-mediated necroptosis
may play important roles in ischemia-induced neuronal and
astrocytic cell death through the activation of autophagic-
lysosomal pathway (Ni et al., 2018). In the same line, breviscapine
provides neuroprotection in the penumbra by decreasing
both astrocytic and neuronal autophagy induced by tMCAo
(Pengyue et al., 2017).
In contrast, inhibition of AMPK, by siRNA targeting
AMPKα1 or by a pharmacological inhibitor, attenuates
autophagy and astrocyte viability following OGD. This work
supports the idea that during ischemia AMPK is involved in
the induction of protective autophagy in astrocytes (Gabryel
et al., 2014). Furthermore, when the astrocytic autophagy is
specifically enhanced, by using AAV-GFAP-ATG7, it leads to
neuroprotection in astrocytes/neurons co-cultures exposed to
OGD and improves neurological outcome following tMCAo
(Liu et al., 2018).
It is important to mention that many inhibitors used in
the autophagy field are not always selective. For example, 3-
MA and wortmannin inhibit both class I and class III PI3K,
and each class of PI3K has its own, and sometimes opposite,
effect on autophagy (Petiot et al., 2000). Furthermore, the use of
rapamycin to inhibit mTORC1 does not only affect autophagy, as
mTORC1 is involved in cell growth, cell survival protein synthesis
and ribosomes biogenesis (Boutouja et al., 2019). Rapamycin
can also inhibit mTOR complex 2, a complex known to have
pro-survival and pro-proliferation effect by increasing Akt and
SGK (Boutouja et al., 2019). The use of these poorly selective
autophagy inhibitors could explain some of the discrepancies
observed in the literature.
ER STRESS AND CEREBRAL ISCHEMIA
Another important consequence of cerebral ischemia is ER
stress. The ER is an important organelle for the folding of
all secreted and membrane proteins. In stress conditions, such
as ischemia, the ER cannot assume correctly its functions and
triggers an adaptive program called the UPR, leading to two
distinct actions: (i) an early inhibition of protein synthesis; (ii)
a delayed upregulation of genes that promote protein folding and
degradation (Marciniak and Ron, 2006).
In Def Webster and Ames (1965), it was first noted that
neurons of the rabbit retinas show swelling of their ER when
subjected to OGD. Although initially reversible, this change
becomes irreversible when OGD lasts more than 30 min. Similar
distension of the ER was subsequently reported in neurons in
a rat model of MCAo reperfusion injury (Dietrich et al., 1989),
implicating ER dysfunction in the complex process of ischemic
neuronal damage.
The threat of ER is detected in cells by three sensors that
are present at the ER membrane, PERK, IRE1, and ATF, each
mediating a separate branch of the UPR (Figure 3).
The PERK branch: the inhibition of protein synthesis is
an early response to ER stress mediated by PERK (PKR-like
endoplasmic reticulum eIF2α kinase) (Harding et al., 1999).
Under physiological conditions, PERK is held inactive by its
binding to the chaperone BiP (binding immunoglobulin protein,
also known as Grp78). Upon stress, the kinase is activated
by the release of BiP and phosphorylates its sole cytoplasmic
target, eIF2α (Marciniak et al., 2006). This is a regulator
of the initiation of protein synthesis. In teleological terms,
a “goal” of the PERK branch activation is to prevent the
further accumulation of misfolded proteins (Roussel et al., 2013).
However, despite a global shutdown of protein translation due to
the phosphorylation of eIF2α, some mRNAs are translated more
efficiently (Harding et al., 2003). This is the case of ATF4, leading
to a transcriptional program of stress-responsive genes including
CHOP (C/EBP homologous protein) (Harding et al., 2003). The
observation that Chop−/− animals and cells are resistant to
ER stress, led some to suggest CHOP functions to promote ER
stress-induced cell death. This is not fully supported, however, by
analysis of the genes regulated by CHOP (Marciniak et al., 2004).
Instead, CHOP appears to regulate a program that promotes
the recovery of protein synthesis and secretion following the
recovery of ER stress. For example, CHOP induces expression
of GADD34 (protein phosphatase 1 regulatory subunit 15A),
which is responsible for the dephosphorylation of eIF2α and
thus the recovery of normal protein translation (Roussel et al.,
2013). In this light, the ATF4-CHOP-GADD34 axis can be
viewed as a negative feedback loop opposing the effects of
PERK. It is therefore likely that the apparent “pro-death”
role that has been attributed to CHOP is too simplistic. The
recovery of translation is essential for normal functioning of
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FIGURE 3 | Endoplasmic reticulum (ER) stress signaling. Under physiological conditions, the Glucose Related Protein 78 (GRP78) binds to the three ER
transmembrane sensors; protein kinase RNA-like ER kinase (PERK), inositol-requiring kinase 1α (IRE1α) and activating transcription factor 6 (ATF6), and maintains
them inactive. Ischemic stroke induces ER stress, leading to the activation of the UPR. Under stress conditions, GRP78 dissociates from the ER sensors to bind to
misfolded proteins, allowing the trans-autophosphorylation of PERK. P-PERK phosphorylates the eukaryotic translation initiation factor 2α (eIF2α), which decreases
the global protein translation. Paradoxically, P-eIF2α allows the transcription of activating transcription factor 4 (ATF4), CCAT/enhancer binding protein homologous
protein (CHOP). Both P-eIF2α and CHOP can activate the translation of growth arrest and DNA damage inducible gene/protein 34 (GADD34). The latter creates a
feedback mechanism by dephosphorylating eiF2α. PERK is associated to apoptosis, autophagy and redox control. IRE1α dimerizes and trans-autophosphorylates,
to splice the unspliced mRNA XBP1 (uXBP1) into spliced XBP1 (sXBP1). IRE1α activates c-jun-N-terminal-inhibiting kinase (JIK) and allows the recruitment of TNF
receptor-associated factor 2 (TRAF2), leading to the activation of nuclear factor κ-B (NFκ-B), caspase 12 and c-jun-N-terminal kinase (JNK) pathway. IRE1α activates
Regulated IRE1-Dependent Decay (RIDD) leading to the degradation of selected mRNAs. IRE1α is also involved in apoptosis, ER-associated degradation (ERAD)
and lipid synthesis. The activation of ATF6 is dependent of its cleavage by S1P and S2P endopeptidases in the Golgi apparatus. Cleaved ATF6 induces the
transcription of GRP78, nitric oxide synthase (NOS) and CHOP. Moreover, cleaved ATF6 controls ERAD, apoptosis and protein folding.
the cell following mild ER stress, but perhaps in pathology,
for example cerebral ischemia, there are benefits from disabling
the normal rapid recovery of protein synthesis. This clearly has
exciting therapeutic implications and many groups are currently
developing approaches to antagonize the ATF4-CHOP-GADD34
axis for therapeutic benefit.
The ATF6 branch: like PERK, ATF6 is held inactive by the
binding to BiP. Under stressed conditions, ATF6 is free to traffic
to the Golgi apparatus where it is cleaved to release a soluble
transcription factor for protein folding and degradation genes
(Hillary and Fitzgerald, 2018).
The IRE1 branch: the activation of IRE1 is similar to that
of ATF6 and PERK, but IRE1 is an endoribonuclease that
triggers the splicing of the mRNA XBP1 (Calfon et al., 2002).
The splicing induces a frameshift, allowing the active form of
the protein. Proteins that fail to fold in the ER are eventually
returned to the cytoplasm and targeted for degradation by the
proteasome in process called ERAD. Many proteins of the ERAD
machinery are induced by XBP1 (Yoshida et al., 2003). During
intense ER stress, IRE1 also degrades many mRNAs located at
the ER membrane through a mechanism called regulated IRE1-
dependent decay (RIDD) (Hollien and Weissman, 2006). This
helps further to reduce the load of new proteins entering the
ER to be folded.
UPR in Cerebral Ischemia
The ER is the main storage site for intracellular calcium, a central
second messenger mediating diverse physiological processes in
neurons, including secretion, synaptic plasticity and cell death
(Zundorf and Reiser, 2011). Molecular chaperones that reside
within the ER require high calcium concentrations to function
efficiently (Michalak et al., 2002). This high calcium environment
is maintained by the constant pumping of calcium from the
cytosol into the ER by the SERCA (Doutheil et al., 1999b).
Release of calcium back into the cytosol happens through the
IP3R channel, which can be triggered by extracellular signals,
or by the ryanodine receptor, activated by cytosolic calcium
itself during CICR. Both lead to signaling but, if sustained, they
deplete ER calcium stores and can induce chaperone dysfunction
(Szydlowska and Tymianski, 2010). During cerebral ischemia, the
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influx of extracellular calcium via the NMDA receptor mediates
glutamate-dependent neurotoxicity (Lopez-Atalaya et al., 2008).
The rise in intracellular calcium triggers the release of ER
calcium from ryanodine-sensitive stores, which is known to
exacerbate CA1 hippocampal neuronal damage during global
cerebral ischemia-reperfusion (Xing et al., 2004; Bull et al., 2008).
Accordingly, inhibition of calcium release with the ryanodine
receptor antagonist dantrolene decreases brain injury in animal
models of both neonatal and adult HI (Wei and Perry, 1996;
Gwak et al., 2008). While commonly attributed to the effects of
cytosolic calcium, it is likely that effects on ER protein folding
will also be important in these pathological conditions. Moreover,
during cerebral ischemia, lack of ATP affects protein maturation
(Kumar et al., 2003), and at the same time energy depletion
leads to failure of the SERCA pumps (Doutheil et al., 1999b),
contributing to the global ER calcium depletion and causing
chaperone failure. Thus, the redistribution of calcium from ER
to cytosol delivers a double blow to neurons, which exacerbates
neurotoxicity (Paschen and Doutheil, 1999; Parsons et al., 1999).
The deregulation of ER-calcium homeostasis causing
chaperone failure and activation of the UPR is readily apparent
in many animal models of cerebral ischemia, including mice with
BCAo (Kumar et al., 2001) or MCAo (Mengesdorf et al., 2002),
rats with middle carotid artery occlusion with (Nakka et al., 2010)
or without (Rissanen et al., 2006) reperfusion, cardiac arrest
with reperfusion (Kumar et al., 2003) and a model of cortical
spreading depression in rats (Schneeloch et al., 2004). This
induction of ER stress during cerebral ischemia is responsible for
the shutdown of protein translation seen during stroke (Burda
et al., 1994; DeGracia et al., 1996; Hayashi et al., 2003; Kumar
et al., 2003). It involves the activation of the stress-sensing PERK
(Kumar et al., 2001; Li et al., 2005; Rissanen et al., 2006) that
phosphorylates the translation initiation factor eIF2α, leading to
the attenuation of new protein synthesis and disaggregation of
polyribosomes (Althausen et al., 2001; Nakka et al., 2010).
Also, CHOP expression is elevated in several animal models
of cerebral ischemia, including MCAo (Qi et al., 2004) and
BCAo in mice (Tajiri et al., 2004; Osada et al., 2009), as well as
MCAo and global ischemia in rats (Hayashi et al., 2005). Chop
knockout (−/−) mice are more resistant to a BCAo type of
ischemia than their wild-type littermates (Tajiri et al., 2004), and
depletion of CHOP using RNA-interference in primary cultures
of astrocytes partially prevents cell death in response to OGD
(Benavides et al., 2005), suggesting that CHOP regulates a genetic
program that is toxic in the context of cerebral ischemia. It has
been shown that GADD34 is a target gene of CHOP responsible
for some of the tissue damage seen in animal models of ER
stress (Marciniak et al., 2004). This phosphatase is induced
under conditions of cerebral ischemia (Doutheil et al., 1999a;
Paschen et al., 2004; Li et al., 2005; Owen et al., 2005) and is
detectable by immunostaining in the peri-infarct penumbra up
to 24 h following the induction of stroke in rats (Imai et al.,
2002; McCaig et al., 2005). As discussed already, it is therefore
plausible that the toxicity attributed to CHOP is in fact the
result of re-established protein translation mediated by GADD34
(Marciniak et al., 2004): it might be a mechanism implicated
in reperfusion-mediated damage in cerebral ischemia. If this
is the case, attenuation of protein translation should protect
neurons from accumulating misfolded proteins. Consistent with
this theory, salubrinal, a putative GADD34 inhibitor, has been
shown to decrease ER stress and kainate-induced neurotoxicity
in vitro (Sokka et al., 2007). However, the specificity of salubrinal
has been questioned many times, since it was first demonstrated
to work only in vivo (Boyce et al., 2005), and more recently its
inhibitory effect has been shown to be really limited (Crespillo-
Casado et al., 2017). IRE1, which splices the mRNA encoding
the transcription factor XBP1, also shows activation during
cerebral ischemia, for example in the cortex of mice after MCAo
(Paschen et al., 2003; Morimoto et al., 2007) and BCAo (Tajiri
et al., 2004). By contrast, ATF6 signaling remains a subject of
debate: ATF6 expression was increased following MCAO in rats
(Rissanen et al., 2006), but activation could not be demonstrated
in an ischemia-reperfusion model by cardiac arrest in rats
(Kumar et al., 2003).
CROSSTALK BETWEEN AUTOPHAGY
AND ER STRESS
Autophagy and ER stress are important signaling pathways,
but when dysregulated can lead to cell death, such like during
cerebral ischemia. A well-balanced activation of these processes
allow the maintenance or the recovery of proteostasis. However,
their over-activation, by duration or intensity, tips the scale
from a protective to a deleterious role (Roussel et al., 2013;
Chen et al., 2014).
Although, as mentioned in the introduction, several
interactions exist between ER stress and autophagy, in
particular when misfolded proteins accumulate within the
ER and activate PERK to induce autophagy (Kouroku et al.,
2007). Moreover, downstream targets of PERK, like ATF4
and CHOP, induce the transcription of genes related to
autophagy in response to both ER stress and amino acid
starvation (B’Chir et al., 2013). During hypoxia, ATF4 facilitates
autophagosome expansion through a binding to a cAMP
response element-binding site within the LC3b promoter
(Rzymski et al., 2010). Other sensors are also involved in
autophagy induction, such as IRE1 by dissociating Beclin1
from its binding with Bcl2 (Wei et al., 2008). In addition, IRE1
also induces autophagy by activating AMPK in response
to nitric oxide (Meares et al., 2011). XBP1, the mRNA
processed by IRE1, is important for the negative feedback
of ER stress-mediated autophagy, especially via its interaction
with FOXO1 (Zhou et al., 2011). Interestingly, a genetic screen
in Drosophila shows that both XBP1 loss of function and
spliced-XBP1 overexpression lead to the induction of autophagy
(Arsham and Neufeld, 2009). Finally, ATF6 has also been
implicated in ER stress-mediated autophagy. By increasing
the expression of DAPK1 (Gade et al., 2014), ATF6 promotes
the dissociation of Beclin1 from Bcl2, leading to autophagy
activation (Zalckvar et al., 2009).
In a mouse model of tMCAo, both ER stress and autophagy
markers increase, suggesting a dual activation of ER stress and
autophagy (Feng et al., 2017). It seems then important when
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studying proteostasis in cerebral ischemia, to pay attention to
both phenomena and not only ER stress or autophagy.
Some studies also demonstrate an action of autophagy on
ER stress. Indeed, the use of 3MA in a rat model of MCAo
alters the ER stress response and leads to the stimulation of
apoptosis and the enlargement of the cerebral infarct (Zhang
et al., 2018). Similarly, Carloni et al. (2014) show a reduced ER
stress activation and a better protection after neonatal HI when
they increase autophagy with rapamycin. A possible explanation
might be that CHOP induces death by inhibiting autophagy
(Lei et al., 2017). This has been demonstrated in hepatocellular
carcinoma cells, where ER stress inducer increases apoptosis and
autophagy, while autophagy inhibitor promotes apoptosis and
autophagy activator decreases ER stress-induced apoptosis (Lei
et al., 2017). However, this hypothesis needs to be confirmed in
neurons under ischemic/hypoxic challenge.
Finally, ER stress has been reported to cause the translocation
of ER chaperones to the cell surface. BiP is the best described
chaperone at the cell surface, and can act as a general co-
receptor (Gonzalez-Gronow et al., 2009), with roles in autophagy,
cancer and neuroprotection (Casas, 2017). Interestingly, cell-
surface BiP can regulate autophagy by at least two mechanisms:
by activating the PI3K/AKT pathway (Liu et al., 2013); and
by associating to α2-macroglobulin receptor to activate mTOR
signaling (Misra and Pizzo, 2012). Under OGD conditions, BiP
is also at the neuronal surface (Louessard et al., 2017), and its
binding to tPA results in a decrease in ER stress activation and
neuroprotection (Louessard et al., 2017). In another model of
hypoxia-induced apoptosis, the activation of neuronal-surface
BiP by a synthetic peptide is also protective (Goldenberg-Cohen
et al., 2012), reinforcing its role in neuroprotection during
cerebral ischemia.
CONCLUSION
Many neurological diseases, including cerebral ischemia, are
associated with complete or partial activation of the UPR,
perturbations in calcium homeostasis, autophagy dysfunctions,
and finally cell death. Both an appreciation of the crucial role
for ER homeostasis, the multiple forms that ER dysfunction can
take, the regulation and the consequences of autophagy are now
providing novel therapeutic strategies.
We propose a model in which proteostasis dysfunction spans a
continuous spectrum from the UPR to autophagy, with probably
a direct regulation of autophagy by the UPR as mentioned
above. In cerebral ischemia, both pathways will be triggered to
a greater or lesser degree, depending of stroke intensity, itself
depending of the occlusion type and localisation. In each case,
the relative contribution of each response and their interactions
would need to be determined if rational approaches to therapy
are to be developed.
Also, special attention should be given to studies using
pharmacological approaches. As scientists, we all know that
pharmacological treatments are really convenient, but we have to
keep in mind that a “specific” drug has a lot of off targets actions.
For example, it has been recently shown that GSK2606414, a
PERK inhibitor, and KIRA6, an IRE1 inhibitor, are not only UPR
specific (Mahameed et al., 2019). In fact they also inhibit KIT
(also called CD117), a receptor tyrosine kinase involved in signal
transduction pathways such as ERK and PI3K/AKT, upstream of
mTOR and autophagy. In fact, many pharmacological activators
and inhibitors are not as specific as they are supposed to be, and
thus participate to discrepancies.
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